TY - JOUR T1 - Tracking Smell Loss to Identify Healthcare Workers with SARS-CoV-2 Infection JF - medRxiv DO - 10.1101/2020.09.07.20188813 SP - 2020.09.07.20188813 AU - Julian J. Weiss AU - Tuki N. Attuquayefio AU - Elizabeth B. White AU - Fangyong Li AU - Rachel S. Herz AU - Theresa L. White AU - Melissa Campbell AU - Bertie Geng AU - Rupak Datta AU - Anne L. Wyllie AU - Nathan D. Grubaugh AU - Arnau Casanovas-Massana AU - M. Catherine Muenker AU - Ryan Handoko AU - Akiko Iwasaki AU - the Yale IMPACT Research Team AU - Richard A. Martinello AU - Albert I. Ko AU - Dana M. Small AU - Shelli F. Farhadian Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/09/10/2020.09.07.20188813.abstract N2 - Background Healthcare workers (HCW) treating COVID-19 patients are at high risk for infection and may also spread infection through their contact with vulnerable patients. Smell loss has been associated with SARS-CoV-2 infection, but it is unknown whether monitoring for smell loss can be used to identify asymptomatic infection among high risk individuals, like HCW.Methods We performed a prospective cohort study, tracking 473 HCW across three months to determine if smell loss could predict SARS-CoV-2 infection in this high-risk group. HCW subjects completed a longitudinal, novel behavioral at-home assessment of smell function with household items, as well as detailed symptom surveys that included a parosmia screening questionnaire, and RT-qPCR testing to identify SARSCoV-2 infection.Results SARS-CoV-2 was identified in 17 (3.6%) of 473 HCW. Among the 17 infected HCW, 53% reported smell loss, and were more likely to report smell loss than COVID-negative HCW on both the at-home assessment and the screening questionnaire (P < .01). 67% reported smell loss prior to having a positive SARS-CoV-2 test, and smell loss was reported a median of two days before testing positive. Neurological symptoms were reported more frequently among COVID-positive HCW who reported smell loss (P < .01).Conclusions In this prospective study of HCW, self-reported changes in smell using two different measures were predictive of COVID-19 infection. Smell loss frequently preceded a positive test and was associated with neurological symptoms.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the National Institutes of Health [K23MH118999 and 1R01AI157488 to SFF], a gift to Yale for DMS from Mr. Brett Wilson, the Beatrice Kleinberg Neuwirth Fund and the Yale Schools of Medicine and Public Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All study participants were enrolled and sampled in accordance to the Yale University HIC-approved protocol #2000027690. Demographics, clinical data and samples were collected after the study participant had acknowledged that they had understood the study protocol and signed the informed consent. All participant information and samples were collected in association with non-individually identifiable study identifiers.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated and/or analysed during the current study are available from the corresponding author on reasonable request. ER -